SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: PawPr who wrote (535)2/1/1998 3:06:00 PM
From: Peter Singleton  Read Replies (1) | Respond to of 965
 
Bruce,

Do you follow Biogen? There's a good thread here on SI. One could make the case that it should be a core biotech holding in any diversified portfolio ... kind of what we used to think about Chiron a couple of years ago.

Peter



To: PawPr who wrote (535)2/1/1998 9:25:00 PM
From: Pancho Villa  Read Replies (1) | Respond to of 965
 
How about OXHP? went up three Friday on takeover rumors but still under 18. I agree. I will cover IPIC, just waitng for what should be an ugly quarterly report. As for Citicoline, you said it, IPIC claims it works. I give it less than a 50% chance of going through smoothly based on currently available trial data.

Pancho


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News